Shandong Boan Biotechnology Salute del bilancio
Salute finanziaria criteri di controllo 3/6
Shandong Boan Biotechnology has a total shareholder equity of CN¥1.4B and total debt of CN¥654.2M, which brings its debt-to-equity ratio to 47%. Its total assets and total liabilities are CN¥2.5B and CN¥1.2B respectively. Shandong Boan Biotechnology's EBIT is CN¥19.8M making its interest coverage ratio 1. It has cash and short-term investments of CN¥172.1M.
Informazioni chiave
47.0%
Rapporto debito/patrimonio netto
CN¥654.23m
Debito
| Indice di copertura degli interessi | 1x |
| Contanti | CN¥172.12m |
| Patrimonio netto | CN¥1.39b |
| Totale passività | CN¥1.16b |
| Totale attività | CN¥2.55b |
Aggiornamenti recenti sulla salute finanziaria
Nessun aggiornamento
Analisi della posizione finanziaria
Passività a breve termine: 6955's short term assets (CN¥749.0M) exceed its short term liabilities (CN¥555.6M).
Passività a lungo termine: 6955's short term assets (CN¥749.0M) exceed its long term liabilities (CN¥601.0M).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: 6955's net debt to equity ratio (34.6%) is considered satisfactory.
Riduzione del debito: Insufficient data to determine if 6955's debt to equity ratio has reduced over the past 5 years.
Copertura del debito: 6955's operating cash flow is negative, therefore debt is not well covered.
Copertura degli interessi: 6955's interest payments on its debt are not well covered by EBIT (1x coverage).